… survival data or include QOL or patient satisfaction data. For this reason, we undertook a
systematic review and meta-analysis of follow-up strategies for both small cell lung cancer (…

… cancer (NSCLC) is highly variable, and retrospective data show a survival advantage for
patients receiving therapeutic intent pulmonary resection. We hypothesized that this variability …

… We investigated whether PFS is an acceptable surrogate for OS in patients with advanced
non-small-cell lung cancer (NSCLC) using individual data from 2334 patients enrolled in five …

… benefits of tumor match and adaptive radiotherapy for a cohort of non-small cell lung cancer
patients (… The survival benefit of adaptiveRT is present despite a somewhat poorer pre-…

… to extend survival in fit patients with advanced non–small-cell lung cancer (AdvNSCLC). This
study extends recent population-based analyses focusing on treatment and survival benefit …

… Background: Survival benefits can be predicted from progression-free survival in
advanced colorectal cancer (Buyse et al, JCO 2007; 25:5218), but not in advanced breast …

… Lung cancer is the leading cause of cancer mortality worldwide. We analyzed changes in
treatment and their potential effect on survival of non-small cell lung cancer (NSCLC) patients …

… To estimate the population-based locoregional control and overall survival benefits of
radiotherapy for lung cancer if the whole population were treated according to evidence-based …

… From this review, the survival benefit obtained with chemotherapy appears to be accompanied
with some improvements of various QoL components, despite the occurrence of side …

… Because these 12 genes are “hubs” of the survival related genes, and play roles in cell …
in lung cancer, we hypothesize that this 12-gene set can predict survival benefits from ACT in …